OTC : CSPCY

CSPC Pharmaceutical Group Limited

$4.09 USD

$0.05 (1.24%)

Volume
444
Average Volume
2.08K
Market Capitalization
$11.78B
P/E Ratio
20.60
Dividend Yield
3.58%
Price Target
Year High
$5.83
Year Low
$3.26
Day High
Day Low
Payout Ratio
$0.64
Current Ratio
$2.19
Source Headline
AstraZeneca signs CSPC China deal for experimental kidney disease drugs

AstraZeneca has entered into a deal ​worth up to $1.77 billion with CSPC ‌Pharmaceutical Group to discover and develop experimental medicines with the potential to treat kidney diseases, ​the Chinese drugmaker said on ​Thursday.

reuters.com - 2026-07-02 06:16:16

Get CSPCY Insider Trade Alerts

CSPCY Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

CSPCY Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade